Implanet received regulatory approval from the Brazilian National Health Surveillance Agency to market its JAZZ Band platform.
Here are four key notes:
1. The JAZZ Band is intended to treat spinal pathologies requiring vertebral fusion surgery.
2. "With its market size and strong pricing, Brazil is a real growth engine on this continent, and this opens the way for additional milestones to be reached," said Ludovic Lastennet, CEO of Implanet.
3. Implanet also recently received FDA 510(k) regulatory clearance to market the JAZZ Band as usable with other posterior thoraco-lumbar fixation systems.
4. Implant is a medical technology company that manufactures implants for orthopedic surgery and the JAZZ Band implant is its flagship product.